GLP-1 agonists are a testament to the progress made in medical science and the commitment to finding solutions that cater to the needs of individuals living with chronic diseases
This extends its utility beyond glucose control
Less Common but Serious Side Effects While rare, some individuals may experience more serious reactions, including: Severe dehydration: If nausea, vomiting, or diarrhea conditions persist, dehydration can become a risk
Adults with obesity and autoimmune disease may have a lower risk of blood clots, pulmonary embolism, ER visits, and death when they use GLP-1 medicines under medical care
Murphy RM, Watt MJ, Febbraio MA
So, the theory goes, Novo Nordisk let its patent lapse early to avoid the potential of more aggressive oversight from the review board, even if it meant having to contend with generics years earlier